In a report released today, Jason Mills from Canaccord Genuity reiterated a Buy rating on Tactile Systems Technology (NASDAQ: TCMD), with a price target of $65. The company’s shares closed yesterday at $48.78.
According to TipRanks.com, Mills is a top 25 analyst with an average return of 31.2% and a 74.9% success rate. Mills covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Staar Surgical Company, and Merit Medical Systems.
Tactile Systems Technology has an analyst consensus of Moderate Buy, with a price target consensus of $49.50.
See today’s analyst top recommended stocks >>
Tactile Systems Technology’s market cap is currently $879.8M and has a P/E ratio of 125.98. The company has a Price to Book ratio of 12.03.
Based on the recent corporate insider activity of 106 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tactile Systems Technology, Inc. is a medical technology company, which develops and provides innovative medical devices for the treatment of chronic diseases at home. The company focus on advancing the standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures. It possess a platform to deliver at-home healthcare solutions throughout the United States. The company was founded on January 30, 1995 and is headquartered in Minneapolis, MN.
